IKT Inhibikase Therapeutics Inc

USD 1.99 +0.03 ( +1.53%)
Icon

Inhibikase Therapeutics Inc (IKT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.99

+0.03 (+1.53%)

USD 0.16B

0.16M

USD 5.00(+151.26%)

N/A

Icon

IKT

Inhibikase Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.99
+0.03 ( +1.53%)

Discussions

No discussions yet.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...